Ultragenyx Pharmaceutical Inc. Insider Trading for June 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for June 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2016 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | A | 54.50 | 60,000 | 3,270,000 | 60,000 | |
| Jun 22 2016 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
| Jun 21 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 54.16 | 650 | 35,204 | 10,569 | 11.2 K to 10.6 K (-5.79 %) |
| Jun 21 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 54.99 | 392 | 21,556 | 11,219 | 11.6 K to 11.2 K (-3.38 %) |
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Option Exercise | A | 65.85 | 3,750 | 246,938 | 3,750 | ||
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Grant | A | 0.00 | 1,875 | 0 | 13,194 | 11.3 K to 13.2 K (+16.57 %) | |
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Option Exercise | A | 65.85 | 3,750 | 246,938 | 3,750 | ||
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Grant | A | 0.00 | 1,875 | 0 | 1,875 | 0 to 1.9 K | |
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Option Exercise | A | 65.85 | 3,750 | 246,938 | 3,750 | ||
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Grant | A | 0.00 | 1,875 | 0 | 1,875 | 0 to 1.9 K | |
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Option Exercise | A | 65.85 | 3,750 | 246,938 | 3,750 | ||
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Grant | A | 0.00 | 1,875 | 0 | 1,875 | 0 to 1.9 K | |
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | Aliski William | Option Exercise | A | 65.85 | 3,750 | 246,938 | 3,750 | ||
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | Aliski William | Grant | A | 0.00 | 1,875 | 0 | 59,985 | 58.1 K to 60 K (+3.23 %) | |
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Option Exercise | A | 65.85 | 3,750 | 246,938 | 3,750 | ||
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Grant | A | 0.00 | 1,875 | 0 | 1,875 | 0 to 1.9 K | |
| Jun 07 2016 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Option Exercise | A | 69.53 | 11,000 | 764,830 | 11,000 | |
| Jun 07 2016 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Option Exercise | A | 69.53 | 11,000 | 764,830 | 11,000 | |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Option Exercise | A | 70.57 | 26,700 | 1,884,219 | 26,700 | |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Grant | A | 0.00 | 4,500 | 0 | 11,611 | 7.1 K to 11.6 K (+63.28 %) |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Option Exercise | A | 70.57 | 63,700 | 4,495,309 | 63,700 | |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Grant | A | 0.00 | 10,700 | 0 | 527,147 | 516.4 K to 527.1 K (+2.07 %) |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Option Exercise | A | 70.57 | 20,200 | 1,425,514 | 20,200 | |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Grant | A | 0.00 | 3,400 | 0 | 13,400 | 10 K to 13.4 K (+34.00 %) |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | SVP and Chief Tech ... | Option Exercise | A | 70.57 | 17,800 | 1,256,146 | 17,800 | |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | SVP and Chief Tech ... | Grant | A | 0.00 | 3,000 | 0 | 9,795 | 6.8 K to 9.8 K (+44.15 %) |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Option Exercise | A | 70.57 | 17,800 | 1,256,146 | 17,800 | |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Grant | A | 0.00 | 3,000 | 0 | 10,500 | 7.5 K to 10.5 K (+40.00 %) |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Senior Vice P ... | Option Exercise | A | 70.57 | 24,000 | 1,693,680 | 24,000 | |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Senior Vice P ... | Grant | A | 0.00 | 4,000 | 0 | 45,387 | 41.4 K to 45.4 K (+9.66 %) |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & Senior Vice P ... | Option Exercise | A | 70.57 | 24,000 | 1,693,680 | 24,000 | |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & Senior Vice P ... | Grant | A | 0.00 | 4,000 | 0 | 73,790 | 69.8 K to 73.8 K (+5.73 %) |